Arcus Biosciences Inc (RCUS)
Drugs • Health Care
Percentage
Change
| Mar 19 | Mar 20 | Feb 21 | Feb 22 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|
Net Income to Common | -283 | -353 | ||||||
Net Income | -283 | -353 | ||||||
Profit | -283 | -353 | ||||||
Net Income Continuing | -283 | -353 | ||||||
Income Tax Expense | -1 | 0 | ||||||
Pretax Income | -282 | -353 | ||||||
Total Non-operating Income | 48 | 33 | ||||||
Operating Income | -330 | -386 | ||||||
Total Revenue | 258 | 247 | ||||||
Total Costs and Expenses | -588 | -633 | ||||||
Operating Expenses | -588 | -633 | ||||||
Impairment Expense | -20 | 0 | ||||||
Research and Development Expenses | -448 | -523 | ||||||
Selling, General & Administrative Expenses | -120 | -110 |